Cargando…

Alzheimer’s disease beyond amyloid: strategies for future therapeutic interventions

Jiong Shi and colleagues discuss recent evidence of clinical trials for Alzheimer’s disease and new development strategies

Detalles Bibliográficos
Autores principales:	Shi, Jiong, Sabbagh, Marwan N, Vellas, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2020
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541037/ https://www.ncbi.nlm.nih.gov/pubmed/33036984 http://dx.doi.org/10.1136/bmj.m3684

Ejemplares similares

Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer’s disease dementia from normal controls: preliminary findings
por: Sabbagh, Marwan N, et al.
Publicado: (2018)

Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies
por: Tousi, Babak, et al.
Publicado: (2021)

Novel Therapeutics in Alzheimer's Disease
por: Sabbagh, Marwan, et al.
Publicado: (2012)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Potential Therapeutic Strategies for Alzheimer's Disease Targeting or Beyond β-Amyloid: Insights from Clinical Trials
por: Jia, Qiutian, et al.
Publicado: (2014)

Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia
por: Decourt, Boris, et al.
Publicado: (2022)

Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data
por: Sabbagh, Marwan N., et al.
Publicado: (2017)

Sleep in Alzheimer's Disease–Beyond Amyloid
por: Holth, Jerrah K., et al.
Publicado: (2016)

Critical Appraisal of Amyloid Lowering Agents in AD
por: Decourt, Boris, et al.
Publicado: (2021)

Integrated Disease Surveillance and Response (IDSR) strategy: current status, challenges and perspectives for the future in Africa
por: Fall, Ibrahima Socé, et al.
Publicado: (2019)

The Cause of Alzheimer’s Disease: The Theory of Multipathology Convergence to Chronic Neuronal Stress
por: Decourt, Boris, et al.
Publicado: (2022)

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
por: Song, Chenghuan, et al.
Publicado: (2022)

Future directions for reducing inequity and maximising impact of child health strategies
por: Dalglish, Sarah L, et al.
Publicado: (2018)

Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy
por: von Schoen-Angerer, Tido, et al.
Publicado: (2023)

Non-Amyloid Approaches to Disease Modification for Alzheimer’s Disease: An EU/US CTAD Task Force Report
por: Gauthier, Serge, et al.
Publicado: (2020)

Beyond amyloid: New approaches to Alzheimer's disease treatment
Publicado: (2020)

Amyloid PET imaging: applications beyond Alzheimer’s disease
por: Catafau, Ana M., et al.
Publicado: (2015)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Florbetaben for PET Imaging of Beta-Amyloid Plaques in the Brain
por: Richards, Danielle, et al.
Publicado: (2014)

Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
por: Tolar, Martin, et al.
Publicado: (2020)

Editorial Introduction to the Special Issue from the International Symposium on Biomarkers for Alzheimer’s Disease and Related Disorders
por: Sabbagh, Marwan N.
Publicado: (2017)

Does informant-based reporting of cognitive symptoms predict amyloid positivity on positron emission tomography?
por: Brunet, Hannah E., et al.
Publicado: (2019)

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2018)

Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis
por: Haytural, Hazal, et al.
Publicado: (2021)

Does Informant-Based Reporting of Cognitive Decline Correlate with Age-Adjusted Hippocampal Volume in Mild Cognitive Impairment and Alzheimer’s Disease?
por: Sabbagh, Marwan, et al.
Publicado: (2021)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Shared metabolic shifts in endothelial cells in stroke and Alzheimer’s disease revealed by integrated analysis
por: Guo, Guangyu, et al.
Publicado: (2023)

Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation
por: Mercuri, Mathew, et al.
Publicado: (2023)

Valuing health as development: going beyond gross domestic product
por: Fan, Victoria Y, et al.
Publicado: (2018)

Adolescent wellbeing in humanitarian and fragile settings: moving beyond rhetoric
por: Singh, Neha S, et al.
Publicado: (2023)

Institutionalising community engagement for quality of care: moving beyond the rhetoric
por: Gilmore, Brynne, et al.
Publicado: (2023)

International migration and health: it is time to go beyond conventional theoretical frameworks
por: Hossin, Muhammad Zakir
Publicado: (2020)

Aiming beyond equality to reach equity: the promise and challenge of quality improvement
por: Hirschhorn, Lisa R, et al.
Publicado: (2021)

Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator
por: Saxena, Abha, et al.
Publicado: (2023)

Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
por: Castello, Michael A, et al.
Publicado: (2014)

COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats
por: Hotez, Peter J, et al.
Publicado: (2023)

A call for citizen science in pandemic preparedness and response: beyond data collection
por: Tan, Yi-Roe, et al.
Publicado: (2022)

Improving access to medicines and beyond: the national volume-based procurement policy in China
por: Zhu, Zheng, et al.
Publicado: (2023)

Blood‐based biomarkers in Alzheimer's disease: Future directions for implementation
por: Suridjan, Ivonne, et al.
Publicado: (2023)

Evidence for clinical interventions targeting the gut microbiome in cardiometabolic disease
por: Ghosh, Tarini Shankar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k5tm528c19c45eh82un4ogfvh1